As filed with the Securities and Exchange Commission on July 24, 2023
Registration No. 333-264256
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-8
REGISTRATION STATEMENT NO. 333-264256
UNDER
THE SECURITIES ACT OF 1933
GreenLight Biosciences Holdings, PBC
(Exact name of registrant as specified in its charter)
| | |
Delaware | | 85-1914700 |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) |
| |
29 Hartwell Avenue Lexington, Massachusetts 02421 | | 02421 |
(Address of Principal Executive Offices) | | (Zip Code) |
GreenLight Biosciences Holdings, PBC 2022 Equity and Incentive Plan
GreenLight Biosciences Holdings, PBC 2022 Employee Stock Purchase Plan
(Full titles of the plans)
Dr. Andrey J. Zarur
President and Chief Executive Officer
29 Hartwell Avenue
Lexington, Massachusetts 02421
(Name and address of agent for service)
(617) 616-8188
(Telephone number, including area code, of agent for service)
Copies to:
Nate Gallon
Noah Kornblith
O’Melveny & Myers LLP
2765 Sand Hill Rd
Menlo Park, California 94025
(650) 473-2604
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| | | | | | |
Large accelerated filer | | ☐ | | Accelerated filer | | ☐ |
| | | |
Non-accelerated filer | | ☒ | | Smaller reporting company | | ☒ |
| | | |
| | | | Emerging growth company | | ☒ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐